AAPL350.69+8.32 (+2.43%) ▲|ABBV293.30+1.99 (+0.68%) ▲|ABT110.48+0.55 (+0.50%) ▲|ACN255.33-5.17 (-1.98%) ▼|ADBE237.28-2.03 (-0.85%) ▼|AMAT374.09+41.38 (+12.44%) ▲|AMD512.92+63.88 (+14.23%) ▲|AMGN464.40+3.98 (+0.86%) ▲|AMT189.45+0.66 (+0.35%) ▲|AMZN268.80+9.50 (+3.66%) ▲|AVGO322.24+28.55 (+9.72%) ▲|AXP325.49+4.50 (+1.40%) ▲|BA173.77+0.37 (+0.21%) ▲|BAC50.87+1.45 (+2.92%) ▲|BKNG163.56+2.90 (+1.80%) ▲|BLK1,223.18+44.31 (+3.76%) ▲|BMY62.44+0.30 (+0.48%) ▲|BNY151.65+3.93 (+2.66%) ▲|BRK-B577.33+6.44 (+1.13%) ▲|C122.25+3.20 (+2.69%) ▲|CAT597.80+39.17 (+7.01%) ▲|CL97.89+1.33 (+1.38%) ▲|CMCSA24.46+0.07 (+0.27%) ▲|COF199.58-2.30 (-1.14%) ▼|COP134.33-1.94 (-1.43%) ▼|COST1,061.71+8.15 (+0.77%) ▲|CRM215.33+1.68 (+0.78%) ▲|CSCO99.26+5.41 (+5.76%) ▲|CVS84.49+0.64 (+0.76%) ▲|CVX210.18-2.43 (-1.14%) ▼|DE695.14+23.49 (+3.50%) ▲|DHR236.17+5.92 (+2.57%) ▲|DIS119.18+2.43 (+2.08%) ▲|DUK128.99+1.21 (+0.95%) ▲|EMR171.54+9.19 (+5.66%) ▲|FDX320.39+12.25 (+3.97%) ▲|GD363.10+9.04 (+2.55%) ▲|GE337.15+13.91 (+4.30%) ▲|GEV836.34+62.23 (+8.04%) ▲|GILD169.74+2.85 (+1.71%) ▲|GM89.90+3.74 (+4.34%) ▲|GOOG287.61+3.68 (+1.30%) ▲|GOOGL289.53+4.75 (+1.67%) ▲|GS909.32+43.50 (+5.02%) ▲|HD356.01+12.54 (+3.65%) ▲|HON229.68+9.63 (+4.38%) ▲|IBM248.63+3.63 (+1.48%) ▲|INTC59.41+3.13 (+5.56%) ▲|INTU337.94-3.56 (-1.04%) ▼|ISRG461.52+8.72 (+1.93%) ▲|JNJ282.27+6.05 (+2.19%) ▲|JPM342.73+8.24 (+2.46%) ▲|KO95.78+0.11 (+0.11%) ▲|LIN522.92+7.67 (+1.49%) ▲|LLY1,418.19+64.19 (+4.74%) ▲|LMT588.14+21.06 (+3.71%) ▲|LOW233.64+9.09 (+4.05%) ▲|LRCX221.58+21.14 (+10.55%) ▲|MA658.62+5.92 (+0.91%) ▲|MCD282.33+5.81 (+2.10%) ▲|MDLZ66.49+0.47 (+0.70%) ▲|MDT103.29+1.49 (+1.46%) ▲|META646.67+36.52 (+5.99%) ▲|MMM190.02+4.87 (+2.63%) ▲|MO75.76-0.36 (-0.47%) ▼|MRK148.12+1.39 (+0.95%) ▲|MS187.68+6.24 (+3.44%) ▲|MSFT547.77+17.16 (+3.23%) ▲|MU739.61+49.61 (+7.19%) ▲|NEE87.19+0.24 (+0.27%) ▲|NFLX63.74+0.33 (+0.51%) ▲|NKE40.07+1.48 (+3.82%) ▲|NOW103.52+1.55 (+1.52%) ▲|NVDA178.11-8.54 (-4.57%) ▼|ORCL119.85+3.75 (+3.23%) ▲|PEP142.31+0.97 (+0.69%) ▲|PFE29.42+0.03 (+0.09%) ▲|PG168.55+3.15 (+1.90%) ▲|PLTR170.42+10.04 (+6.26%) ▲|PM193.24-4.64 (-2.34%) ▼|QCOM172.34+6.93 (+4.19%) ▲|RTX196.82+7.29 (+3.85%) ▲|SBUX110.06+4.65 (+4.41%) ▲|SCHW93.23+1.74 (+1.90%) ▲|SO93.80+1.46 (+1.58%) ▲|SPG233.06+4.64 (+2.03%) ▲|T21.65+0.02 (+0.07%) ▲|TMO720.46+25.70 (+3.70%) ▲|TMUS168.60+6.59 (+4.07%) ▲|TSLA381.00+22.78 (+6.36%) ▲|TXN295.80+18.44 (+6.65%) ▲|UBER71.06+2.47 (+3.60%) ▲|UNH396.99+2.84 (+0.72%) ▲|UNP296.64+6.48 (+2.23%) ▲|UPS111.69+3.39 (+3.13%) ▲|USB61.15+1.70 (+2.85%) ▲|V422.36-0.30 (-0.07%) ▼|VZ45.95+0.26 (+0.56%) ▲|WFC85.80+1.86 (+2.22%) ▲|WMT125.63+0.11 (+0.09%) ▲|XOM164.47-1.41 (-0.85%) ▼|AAPL350.69+8.32 (+2.43%) ▲|ABBV293.30+1.99 (+0.68%) ▲|ABT110.48+0.55 (+0.50%) ▲|ACN255.33-5.17 (-1.98%) ▼|ADBE237.28-2.03 (-0.85%) ▼|AMAT374.09+41.38 (+12.44%) ▲|AMD512.92+63.88 (+14.23%) ▲|AMGN464.40+3.98 (+0.86%) ▲|AMT189.45+0.66 (+0.35%) ▲|AMZN268.80+9.50 (+3.66%) ▲|AVGO322.24+28.55 (+9.72%) ▲|AXP325.49+4.50 (+1.40%) ▲|BA173.77+0.37 (+0.21%) ▲|BAC50.87+1.45 (+2.92%) ▲|BKNG163.56+2.90 (+1.80%) ▲|BLK1,223.18+44.31 (+3.76%) ▲|BMY62.44+0.30 (+0.48%) ▲|BNY151.65+3.93 (+2.66%) ▲|BRK-B577.33+6.44 (+1.13%) ▲|C122.25+3.20 (+2.69%) ▲|CAT597.80+39.17 (+7.01%) ▲|CL97.89+1.33 (+1.38%) ▲|CMCSA24.46+0.07 (+0.27%) ▲|COF199.58-2.30 (-1.14%) ▼|COP134.33-1.94 (-1.43%) ▼|COST1,061.71+8.15 (+0.77%) ▲|CRM215.33+1.68 (+0.78%) ▲|CSCO99.26+5.41 (+5.76%) ▲|CVS84.49+0.64 (+0.76%) ▲|CVX210.18-2.43 (-1.14%) ▼|DE695.14+23.49 (+3.50%) ▲|DHR236.17+5.92 (+2.57%) ▲|DIS119.18+2.43 (+2.08%) ▲|DUK128.99+1.21 (+0.95%) ▲|EMR171.54+9.19 (+5.66%) ▲|FDX320.39+12.25 (+3.97%) ▲|GD363.10+9.04 (+2.55%) ▲|GE337.15+13.91 (+4.30%) ▲|GEV836.34+62.23 (+8.04%) ▲|GILD169.74+2.85 (+1.71%) ▲|GM89.90+3.74 (+4.34%) ▲|GOOG287.61+3.68 (+1.30%) ▲|GOOGL289.53+4.75 (+1.67%) ▲|GS909.32+43.50 (+5.02%) ▲|HD356.01+12.54 (+3.65%) ▲|HON229.68+9.63 (+4.38%) ▲|IBM248.63+3.63 (+1.48%) ▲|INTC59.41+3.13 (+5.56%) ▲|INTU337.94-3.56 (-1.04%) ▼|ISRG461.52+8.72 (+1.93%) ▲|JNJ282.27+6.05 (+2.19%) ▲|JPM342.73+8.24 (+2.46%) ▲|KO95.78+0.11 (+0.11%) ▲|LIN522.92+7.67 (+1.49%) ▲|LLY1,418.19+64.19 (+4.74%) ▲|LMT588.14+21.06 (+3.71%) ▲|LOW233.64+9.09 (+4.05%) ▲|LRCX221.58+21.14 (+10.55%) ▲|MA658.62+5.92 (+0.91%) ▲|MCD282.33+5.81 (+2.10%) ▲|MDLZ66.49+0.47 (+0.70%) ▲|MDT103.29+1.49 (+1.46%) ▲|META646.67+36.52 (+5.99%) ▲|MMM190.02+4.87 (+2.63%) ▲|MO75.76-0.36 (-0.47%) ▼|MRK148.12+1.39 (+0.95%) ▲|MS187.68+6.24 (+3.44%) ▲|MSFT547.77+17.16 (+3.23%) ▲|MU739.61+49.61 (+7.19%) ▲|NEE87.19+0.24 (+0.27%) ▲|NFLX63.74+0.33 (+0.51%) ▲|NKE40.07+1.48 (+3.82%) ▲|NOW103.52+1.55 (+1.52%) ▲|NVDA178.11-8.54 (-4.57%) ▼|ORCL119.85+3.75 (+3.23%) ▲|PEP142.31+0.97 (+0.69%) ▲|PFE29.42+0.03 (+0.09%) ▲|PG168.55+3.15 (+1.90%) ▲|PLTR170.42+10.04 (+6.26%) ▲|PM193.24-4.64 (-2.34%) ▼|QCOM172.34+6.93 (+4.19%) ▲|RTX196.82+7.29 (+3.85%) ▲|SBUX110.06+4.65 (+4.41%) ▲|SCHW93.23+1.74 (+1.90%) ▲|SO93.80+1.46 (+1.58%) ▲|SPG233.06+4.64 (+2.03%) ▲|T21.65+0.02 (+0.07%) ▲|TMO720.46+25.70 (+3.70%) ▲|TMUS168.60+6.59 (+4.07%) ▲|TSLA381.00+22.78 (+6.36%) ▲|TXN295.80+18.44 (+6.65%) ▲|UBER71.06+2.47 (+3.60%) ▲|UNH396.99+2.84 (+0.72%) ▲|UNP296.64+6.48 (+2.23%) ▲|UPS111.69+3.39 (+3.13%) ▲|USB61.15+1.70 (+2.85%) ▲|V422.36-0.30 (-0.07%) ▼|VZ45.95+0.26 (+0.56%) ▲|WFC85.80+1.86 (+2.22%) ▲|WMT125.63+0.11 (+0.09%) ▲|XOM164.47-1.41 (-0.85%) ▼|
13.7 C
New York
Monday, November 9, 2026

Tag: development

Embassy Bancorp, Inc. Announces Results of Operations as of and for the Three and Six Months Ended June 30, 2025

Embassy Bancorp, Inc. Announces Results of Operations as of and for the Three and Six Months Ended June 30, 2025

Nabors Energy Transition Corp. II Announces Extension of Deadline to Complete Business Combination

HOUSTON, Aug. 15, 2025 /PRNewswire/ -- Nabors Energy Transition Corp. II (Nasdaq: NETD) ("NETD" or the "Company") announced that its board of directors has elected...

Peyto Exploration & Development Corp. Confirms Monthly Dividend for September 15, 2025

CALGARY, Alberta, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Peyto Exploration & Development Corp. (TSX: PEY) ("Peyto") confirms that the monthly dividend with respect to August 2025 of $0.11 per common share is to be paid on September 15, 2025, for shareholders of record on August 31, 2025.

KinderCare Learning (KLC) Faces IPO Investor Securities Class Action Amid Claims of Child Neglect – Hagens Berman

SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Gollapalli v. KinderCare Learning Companies, Inc., et al., No. 3:25-cv-01424 (D. Or.) has been filed and seeks to represent investors who purchased KinderCare (NYSE: KLC) common stock in or traceable to the company’s October 2024 IPO.

BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering

Offering Structured to Accelerate Streamex’s Operational Build-Out, Strategically Allocated with No Warrants
Offering Structured to Accelerate Streamex’s Operational Build-Out, Strategically Allocated with No Warrants

TARGA ANNOUNCES UPSIZED NON-BROKERED PRIVATE PLACEMENT OF FLOW THROUGH SHARES FOR GROSS PROCEEDS OF UP TO $950,000

/NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES./ CSE: TEX | OTCQB: TRGEF | FRA: V6Y VANCOUVER, BC,...

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

   
- Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial

Nutex Health (NUTX) Delays Filing Quarterly Report, Shares Tank Again After Critical Blue Orca Report — Hagens Berman

SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Shares of Nutex Health Inc. (NASDAQ: NUTX) experienced a precipitous decline today, falling as much as 24% in intraday trading. The significant drop followed the company’s disclosure that it would not timely submit its financial results for the quarter ended June 30, 2025 - a development related to an ongoing investigation by law firm Hagens Berman into possible securities violations.

Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001

Jabez Biosciences Announces Opening of Second Clinical Site in Phase 1 study in Solid Tumors and NHL

4DMT Announces New Employment Inducement Grants

EMERYVILLE, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on August 12, 2025, the compensation committee of the Company’s board of directors granted three new non-executive employees 58,900 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company’s 2025 Employment Inducement Award Plan, which was approved by the Company’s board of directors in February 2025 under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.

Ebang International Holdings Inc. Reports Unaudited Financial Results for the First Six Months of Fiscal Year 2025

SINGAPORE, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the “Company,” “we,” “us” or “our”), today announced its unaudited financial results for the first six months of fiscal year 2025.

Ethereum ETH Gains Momentum as Ethereum-Based MAGACOIN FINANCE Announces Completion of $12 Million Strategic Raise

NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The price of Ethereum (ETH) has shown notable strength over the past 24 hours, trading in the range of $4,619.49 to $4,788.55 (source: CoinMarketCap, August 15, 2025). Against this positive market backdrop, MAGACOIN FINANCE, an Ethereum-based blockchain project, has confirmed the successful close of its $12 million strategic funding round, supported by more than 10,000 verified participants — including a substantial group of early presale contributors.

Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment